In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Feda E MohamedDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.ORCID 0000-0003-0110-2351 Mohammed TabouniDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.
Joanne TrinhInstitute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.
Ibrahim BaydounDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.
Praseetha KizhakkedathDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.ORCID 0000-0003-2687-6476 Hiba AlblooshiDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.
Qudsia ShaukatDepartment of Pediatrics, Tawam Hospital, Al Ain 15258, United Arab Emirates.
Rim AmouriNeurology's Department, Mongi Ben Hmida National Institute of Neurology, Tunis 1007, Tunisia.
Samia Ben SassiNeurology's Department, Mongi Ben Hmida National Institute of Neurology, Tunis 1007, Tunisia.
Fatma Al-JasmiDepartment of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain 15551, United Arab Emirates.
Funding
ASPIRE, the technology program management pillar of Abu Dhabi's Advanced Technology Re-search Council (ATRC), via the ASPIRE Precision Medicine Research Institute Abu Dhabi (AS-PIREPMRIAD) VRI-20-10the Province of British Columbia, LifeLabs and Genome BC for the Leading Edge Endowment Funds BC Leadership Chair (MJF) and Heisenberg Grant (JT)
6 · The paper itselfAbstract
Sepiapterin Reductase Deficiency (SRD) is a rare inherited neurometabolic disorder caused by variants in the
Indexed as
Alcohol OxidoreductasesMutationBiopterinsChildChild, PreschoolExome SequencingFemaleHumansMalePedigreeAlcohol OxidoreductasesBiopterinssepiapterin reductaseataxiacognitive delaydevelopmental delayneurotransmitter disordersparkinsonism
Identifiers
PMID40243727
PMCPMC11988716
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390